Adult Vaccines Market & Forecast - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Adult Vaccines Market & Forecast

Description:

iGATE RESEARCH report entitled “Global - Adult Vaccines Market & Company Analysis to 2020” is a 232 page report with 142 Figures and 8 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape. Click here to view the complete report: Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com – PowerPoint PPT presentation

Number of Views:33

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Adult Vaccines Market & Forecast


1
(No Transcript)
2
Table of Contents
  • Executive Summary
  • 2. Global - Adult Vaccines Analysis and Forecast
    (2007 - 2020)
  • 2.1 Global Adult Vaccines Market and Forecast
  • 2.2 Global Adult Vaccines - Number of Adults
    Vaccinated and Forecast
  • 3. Global Adult Vaccine Market Share Analysis and
    Forecast (2010 - 2020)
  • 3.1 Global Adult Vaccines - Disease Wise Adults
    Vaccinated Share and Forecast
  • 3.2 Global Adult Vaccines - Disease Wise Market
    Share and Forecast
  • 3.3 Global Adult Vaccines - Company Wise Market
    Share and Forecast

3
Continue (www.igateresearch.com)
3.4 Companies Adult Vaccines - Disease Wise Sales
Share and Forecast 3.4.1 GlaxoSmithKline (GSK) -
Adult Vaccines Sales Share and Forecast 3.4.2 Sano
fi Pasteur - Adult Vaccines Sales Share and
Forecast 3.4.3 Merck - Adult Vaccines Sales Share
and Forecast 3.4.4 Novartis - Adult Vaccines
Sales Share and Forecast
4
Continue (www.igateresearch.com)
3.5 Adult Vaccine Disease Wise Market - Company
Share and Forecast 3.5.1 Influenza Adult
Vaccines - Company Market Share and
Forecast 3.5.2 Cervical Cancer/HPV Adult Vaccines
- Company Market Share and Forecast 3.5.3 Hepatiti
s Adult Vaccines - Company Market Share and
Forecast 3.5.4 Pneumococcal Adult Vaccines -
Company Market Share and Forecast 3.5.5 Meningococ
cal Adult Vaccines - Company Market Share and
Forecast 3.5.6 DTP (Diphtheria, Tetanus,
Pertussis) Adult Vaccines - Company Market Share
and Forecast 3.6 Global Adult Vaccines Market -
Region Wise Share and Forecast
5
4. Global Adult Vaccine Market - Disease Wise
Analysis
4.1 Influenza - Adult Vaccine Analysis and
Forecast (2007 - 2020) 4.1.1 Influenza - Adult
Vaccine Market and Forecast 4.1.2 Influenza -
Number of Adults Vaccinated and
Forecast 4.1.3 Influenza - Number of Vaccines
Doses and Forecast 4.2 Cervical Cancer/ HPV -
Adult Vaccine Analysis and Forecast (2007 - 2020)
4.2.1 Cervical Cancer/ HPV - Adult Vaccine
Market and Forecast 4.2.2 Cervical Cancer/ HPV -
Number of Adults Vaccinated and
Forecast 4.2.3 Cervical Cancer/ HPV - Number of
Vaccines Doses and Forecast
6
Continue (www.igateresearch.com)
4.3 Zoster Shingles - Adult Vaccine Analysis and
Forecast (2007 - 2020) 4.3.1 Zoster Shingles -
Adult Vaccine Market and Forecast 4.3.2 Zoster
Shingles - Number of Adults Vaccinated and
Forecast 4.3.3 Zoster Shingles - Number of
Vaccines Doses and Forecast 4.4 Pneumococcal -
Adult Vaccine Analysis and Forecast (2010 -
2020) 4.4.1 Pneumococcal - Adult Vaccine Market
and Forecast 4.4.2 Pneumococcal - Number of
Adults Vaccinated and Forecast 4.4.3 Pneumococcal
- Number of Vaccines Doses and Forecast
7
Continue (www.igateresearch.com)
4.5 Meningococcal - Adult Vaccine Analysis and
Forecast (2010 - 2020) 4.5.1 Meningococcal -
Adult Vaccine Market and Forecast 4.5.2
Meningococcal - Number of Adults Vaccinated and
Forecast 4.5.3 Meningococcal - Number of Vaccines
Doses and Forecast 4.6 Measles, Mumps, Rubella
and Varicella (MMRV) - Adult Vaccine Analysis and
Forecast (2010 - 2020) 4.6.1 MMRV - Adult
Vaccine Market and Forecast 4.6.2 MMRV - Number
of Adults Vaccinated and Forecast 4.6.3 MMRV-
Number of Vaccines Doses and Forecast
8
Continue (www.igateresearch.com)
4.7 Hepatitis - Adult Vaccine Analysis and
Forecast (2007 - 2020) 4.7.1 Hepatitis - Adult
Vaccine Market and Forecast 4.7.2 Hepatitis -
Number of Adults Vaccinated and Forecast 4.7.3
Hepatitis - Number of Vaccines Doses and
Forecast 4.8 DTP - Adult Vaccine Analysis and
Forecast (2007 - 2020) 4.8.1 DTP - Adult
Vaccine Market and Forecast 4.8.2 DTP - Number of
Adults Vaccinated and Forecast 4.8.3 DTP - Number
of Vaccines Doses and Forecast 4.9 Travel and
Miscellaneous - Adult Vaccine Analysis and
Forecast (2007 - 2020)
9
5. Global Adult Vaccine Market - Company Analysis
Strategic Alliances
5.1 GlaxoSmithKline 5.1.1 GlaxoSmithKline (GSK)
- Adult Vaccine Sales and Forecast 5.1.2 Strategic
Alliances of GlaxoSmithKline (GSK) 5.2 Sanofi
Pasteur 5.2.1 Sanofi Pasteur Vaccines Sales and
Forecast 5.2.2 Strategic Alliances of Sanofi
Pasteur 5.3 Merck 5.3.1 Merck Vaccines Sales
and Forecast 5.3.2 Strategic Alliances of Merck
10
Continue (www.igateresearch.com)
5.4 Novartis 5.4.1 Novartis Vaccines Sales and
Forecast 5.4.2 Strategic Alliances of
Novartis 5.5 Pfizer 5.5.1 Pfizer Adult Vaccines
Sales and Forecast 5.5.2 Strategic Alliances of
Pfizer 5.6 Other Companies Sales and Forecast
11
6. Global Adult Vaccine - Disease Wise Company
Sales and Forecast (2007 - 2020)
6.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales
and Forecast 6.1.1 GlaxoSmithKline (GSK) -
Influenza Adult Vaccines Sales and
Forecast 6.1.2 GlaxoSmithKline (GSK) - Cervical
Cancer/HPV Adult Vaccines Sales and
Forecast 6.1.3 GlaxoSmithKline (GSK) - Hepatitis
Adult Vaccines Sales and Forecast 6.1.4 GlaxoSmith
Kline (GSK) - DTP Adult Vaccines Sales and
Forecast
12
Continue (www.igateresearch.com)
6.2 Sanofi Pasteur - Adult Vaccines Sales and
Forecast 6.2.1 Sanofi Pasteur - Influenza Adult
Vaccines Sales and Forecast 6.2.2 Sanofi Pasteur
- DTP Adult Vaccines Sales and Forecast 6.2.3 Sano
fi Pasteur - Meningococcal Adult Vaccines Sales
and Forecast
13
Continue (www.igateresearch.com)
6.3 Merck - Adult Vaccines Sales and
Forecast 6.3.1 Merck/CSL - Influenza Adult
Vaccines Sales and Forecast 6.3.2 Merck -
Cervical Cancer/HPV Adult Vaccines Sales and
Forecast 6.3.3 Merck - Zoster Shingles Adult
Vaccines Sales and Forecast 6.3.4 Merck -
Pneumococcal Adult Vaccines Sales and
Forecast 6.3.5 Merck - MMRV Adult Vaccines Sales
and Forecast 6.3.6 Merck - Hepatitis Adult
Vaccines Sales and Forecast
14
Continue (www.igateresearch.com)
6.4 Novartis - Adult Vaccines Sales and
Forecast 6.4.1 Novartis - Influenza Adult
Vaccines Sales and Forecast 6.4.2 Novartis -
Meningococcal Adult Vaccines Sales and
Forecast 6.5 Pfizer - Adult Vaccines Sales and
Forecast 6.5.1 Pfizer - Pneumococcal Adult
Vaccines Sales and Forecast
15
7. Global Adult Vaccine Market - Regional
Distribution (2011 - 2020)
7.1 United States - Adult Vaccine Market and
Forecast 7.2 North America/Caribbean - Adult
Vaccine Market and Forecast 7.3 South America -
Adult Vaccine Market and Forecast 7.4 Europe -
Adult Vaccine Market and Forecast 7.5 Japan -
Adult Vaccine Market and Forecast 7.6 India -
Adult Vaccine Market and Forecast 7.7 China -
Adult Vaccine Market and Forecast 7.8 Rest of the
World (ROW) - Adult Vaccine Market and
Forecast 8. Major Vaccine Related Acquisitions
(2005-2015)
16
9. Adult Vaccines Market - Driving Factors
9.1 GAVI Model Fuelling Vaccine
Manufacturers 9.1.1 The Partnership
Model 9.1.2 The Business Model 9.2 Global
Immunization Vision and Strategy (GIVS)
9.3 Growing Vaccine Availability in United
States 9.4 The Vaccine Injury Compensation
Program 9.5 The Vaccine Safety Data link
Project 9.6 Transformation of Vaccine
Technologies 9.7 Global Vaccine Action Plan by
WHO (2011 - 2020) 9.8 Continuous Focus on
Effective Communication Strategies
17
10. Adult Vaccines Market - Challenges
10.1 Hurdles to Optimal use of Licensed
Vaccines 10.2 Shortening the Timeline for Vaccine
Development 10.3 Complexity of Vaccine
Development and Approval System Thwarts Product
Development 10.4 Refusal/Resistance to
Vaccination 10.5 Vaccine Adverse Event Reporting
System 10.6 Vaccine Shortages and
Delays 10.7 Obstacles in Vaccine Research and
Development 10.8 Barriers to New Entrants in the
Vaccines Market
18
Source of Information
iGATE RESEARCH employs rigorous primary and
secondary research techniques in developing
distinctive data sets and research material for
business reports. This report is built by using
data and information sourced from Proprietary
Information Database, Primary and Secondary
Research Methodologies, and In house analysis by
iGATE Research dedicated team of qualified
professionals with deep industry experience and
expertise.
19
Published By
iGATE RESEARCH Phone 91-858-684-0791
(India) 91-706-527-9335 (India)
Email info_at_igateresearch.com Internet
www.igateresearch.com          
20
Format
Report Title Global - Adult Vaccines Market
Company Analysis to 2020 To Order the Report
Visit http//www.igateresearch.com/ProductDetai
l.php?pd_nameGlobal20-20Adult20Vaccines20Mark
et2020Analysis20to202020
Single User License US 1,490
Hard-copy Mail Delivery US 1,600
CD-ROM Mail Delivery US 1,550
Multi User License US 2,000

21
Order the Report
iGATE RESEARCH PVT. LTD. Web www.igateresearch.c
om To order the Report E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA) For
Report Related Query E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA)
About PowerShow.com